PriceTargets.com logo

Strata Critical Medical - SRTA Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $8.00
  • Forecasted Upside: 45.72%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 1 Strong Buy Ratings
$5.49 As of 06/23/2026 03:57 PM ET
▼ -0.26 (-4.52%)

This chart shows the closing price for SRTA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Strata Critical Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SRTA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SRTA

Analyst Price Target is $8.00
▲ +45.72% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Strata Critical Medical in the last 3 months. The average price target is $8.00, with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 45.72% upside from the last price of $5.49.

This chart shows the closing price for SRTA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in Strata Critical Medical. This rating has held steady since March 2026, when it changed from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/29/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/27/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/23/2026
  • 1 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/22/2026

Latest Recommendations

  • 1 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/11/2026Weiss RatingsUpgradeHold (C-) ➝ Hold (C)
3/26/2026Zacks ResearchUpgradeHold
3/25/2026Craig HallumInitiated CoverageBuy$8.00
3/25/2026B. Riley FinancialInitiated CoverageBuy$8.00
3/24/2026Weiss RatingsInitiated CoverageHold (C-)
3/24/2026B. Riley FinancialUpgradeStrong-Buy
(Data available from 6/23/2021 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/24/2026
  • 2 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
6/23/2026

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Strata Critical Medical

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Read More

Today's Range

Now: $5.49
Low: $5.48
High: $5.78

50 Day Range

MA: $5.42
Low: $4.04
High: $6.47

52 Week Range

Now: $5.49
Low: $3.67
High: $6.50

Volume

784,560 shs

Average Volume

921,636 shs

Market Capitalization

$475.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Strata Critical Medical?

The following Wall Street sell-side analysts have issued stock ratings on Strata Critical Medical in the last year: B. Riley Financial, Inc., Craig Hallum, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for SRTA.

What is the current price target for Strata Critical Medical?

0 Wall Street analysts have set twelve-month price targets for Strata Critical Medical in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 45.7%. Craig Hallum has the highest price target set, predicting SRTA will reach $8.00 in the next twelve months. Craig Hallum has the lowest price target set, forecasting a price of $8.00 for Strata Critical Medical in the next year.
View the latest price targets for SRTA.

What is the current consensus analyst rating for Strata Critical Medical?

Strata Critical Medical currently has 2 hold ratings, 1 buy rating and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SRTA.

What other companies compete with Strata Critical Medical?

Other companies that are similar to Strata Critical Medical include Costamare, Dorian LPG, Genesis Energy, Flex LNG and Lindblad Expeditions. Learn More about companies similar to Strata Critical Medical.

How do I contact Strata Critical Medical's investor relations team?

Strata Critical Medical's physical mailing address is 55 HUDSON YARDS, 14TH FLOOR, NEW YORK, NY, 10001. The company's listed phone number is (212) 967-1009 and its investor relations email address is [email protected]. The official website for Strata Critical Medical is blade.com. Learn More about contacing Strata Critical Medical investor relations.